Wei-Li Shao Sells 5,618 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) President Wei-Li Shao sold 5,618 shares of the stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $16.13, for a total transaction of $90,618.34. Following the completion of the sale, the president directly owned 69,079 shares in the company, valued at $1,114,244.27. This trade represents a 7.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Omada Health Price Performance

Shares of NASDAQ OMDA opened at $15.78 on Thursday. Omada Health, Inc. has a 1 year low of $14.14 and a 1 year high of $28.40. The firm has a 50-day simple moving average of $18.97 and a two-hundred day simple moving average of $20.03.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. Morgan Stanley set a $32.00 price objective on Omada Health in a research report on Thursday, December 18th. Needham & Company LLC upped their price target on shares of Omada Health from $26.00 to $28.00 and gave the stock a “buy” rating in a report on Friday, November 7th. Evercore ISI raised their price target on shares of Omada Health from $27.00 to $28.00 and gave the stock an “outperform” rating in a research note on Friday, November 7th. Baird R W raised shares of Omada Health to a “hold” rating in a research report on Friday, September 5th. Finally, BMO Capital Markets started coverage on shares of Omada Health in a research note on Thursday, November 13th. They issued an “outperform” rating and a $27.00 target price on the stock. Eight investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $27.11.

Hedge Funds Weigh In On Omada Health

Several institutional investors have recently bought and sold shares of the business. Sanofi purchased a new stake in Omada Health during the second quarter worth $9,606,000. Teacher Retirement System of Texas bought a new position in shares of Omada Health in the 2nd quarter worth $640,000. Jennison Associates LLC purchased a new stake in shares of Omada Health during the 2nd quarter worth $4,580,000. Emerald Advisers LLC bought a new stake in Omada Health during the second quarter valued at about $5,089,000. Finally, Emerald Mutual Fund Advisers Trust purchased a new position in Omada Health in the second quarter valued at about $2,950,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.